Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE178561 | GEO | 2021/06/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity II

Project description:Hyperglycemia-induced damage to bone formations and function has been recognized.However, as the largest connective tissue organ, whether bone and osteocytes in turn regulate blood sugar and insulin sensitivity has not been addressed. Here we identified a novel protein termed intraflagellar transport 140 with functional importance in regulating osteogenesis, which is also related to the osteoblastic insulin sensitivity. We established Ift140 osteoblastic conditional knockout mice model, and found that blood glucose metabolism could be regulated through osteoblastic IFT140 interacting with O-GlcNAc transferase to regulate insulin signaling. The discovery provides new insight for two-way regulation between bone and glucose metabolism, and also exploring potential new target for blood glucose interventions.

2021-06-24 | GSE178558 | GEO

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity I

2021-06-24 | GSE178548 | GEO

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity

Project description:Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity

| PRJNA739651 | ENA

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity I

Project description:Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity I

| PRJNA739643 | ENA

Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity II

Project description:Osteoblast-derived intraflagellar transport 140 suppresses insulin sensitivity II

| PRJNA739660 | ENA

Inhibiting phosphatidylcholine remodeling in adipose tissue increases insulin sensitivity

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-07-16 | GSE235304 | GEO

Dynamic changes of muscle insulin sensitivity after metabolic surgery

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-08-14 | GSE135066 | GEO

Cross-species Gene Expression Analysis Identifies a Novel Set of Genes Implicated in Human Insulin Sensitivity

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-12-09 | E-GEOD-73037 | biostudies-arrayexpress

Ablation of adipocyte BCL6 enhances subcutaneous adiposity and insulin sensitivity

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-02-26 | GSE113408 | GEO

Intraflagellar Transport and Ciliary Dynamics.

Project description:Cilia and flagella are microtubule-based organelles whose assembly requires a motile process, known as intraflagellar transport (IFT), to bring tubulin and other components to the distal tip of the growing structure. The IFT system uses a multiprotein complex with components that appear to be specialized for the transport of different sets of cargo proteins. The mechanisms by which cargo is selected for ciliary import and transport by IFT remain an area of active research. The complex dynamics of cilia and flagella are under constant regulation to ensure proper length control, and this regulation appears to involve regulation at the stage of IFT injection into the flagellum, as well as regulation of flagellar disassembly and, possibly, of cargo binding. Cilia and flagella thus represent a convenient model system to study how multiple motile and signaling pathways cooperate to control the assembly and dynamics of a complex cellular structure.

| S-EPMC5334256 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data